Completed PHASE4 INTERVENTIONAL 2-arm NCT03091881

Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension

Attenuation of Spinal Induced Hypotension With Granisetron in Type I Diabetic Parturients

Sponsor: Suez Canal University

Interventions Granisetron 0.1 MG/ML Placebos

Updated 8 times since 2017 Last updated: Jun 6, 2022 Started: Mar 1, 2018 Primary completion: Sep 1, 2018 Completion: Nov 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Spinal-induced Hypotension and is currently completed. Suez Canal University leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — Jul 2022 [monthly]

Unknown Status PHASE4
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Aug 2018 — Jul 2020 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting PHASE4
May 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Suez Canal University

Data source: Suez Canal University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ismailia, Egypt